Bartoll, A., Toledano‐Zaragoza, A., Casas, J., Guzmán, M., Schuchman, E. H., & Ledesma, M. D. (2020). Inhibition of fatty acid amide hydrolase prevents pathology in neurovisceral acid sphingomyelinase deficiency by rescuing defective endocannabinoid signaling.
Citación estilo ChicagoBartoll, Adrián, Ana Toledano‐Zaragoza, Josefina Casas, Manuel Guzmán, Edward H. Schuchman, y M. Dolores Ledesma. Inhibition of Fatty Acid Amide Hydrolase Prevents Pathology in Neurovisceral Acid Sphingomyelinase Deficiency By Rescuing Defective Endocannabinoid Signaling. 2020.
Cita MLABartoll, Adrián, et al. Inhibition of Fatty Acid Amide Hydrolase Prevents Pathology in Neurovisceral Acid Sphingomyelinase Deficiency By Rescuing Defective Endocannabinoid Signaling. 2020.